Company Data
Arbutus Biopharma Corporation
Ticker
ABUS
Current Price
$4.06 -13.62%
Market Cap
$780.8M
Price Target
Refer to Report
Volume
8.5M
52wk Range
$2.705 - $5.1
Overview
Arbutus Biopharma Corp is a pharmaceutical company. It discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology.